Market Cap 1.29B
Revenue (ttm) 81.39M
Net Income (ttm) -114.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -140.31%
Debt to Equity Ratio -0.85
Volume 1,121,300
Avg Vol 920,564
Day's Range N/A - N/A
Shares Out 92.61M
Stochastic %K 99%
Beta 1.20
Analysts Strong Sell
Price Target $28.25

Company Profile

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RP...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 860 7985
Address:
655 Third Avenue, Suite 1115, New York, United States
topstockalerts
topstockalerts Jul. 3 at 10:41 PM
$MGTX not chasing but definitely watching this closely
0 · Reply
EddieHayes
EddieHayes Jul. 2 at 10:35 PM
$TECX $MRNA $MGTX and a cluster of names just printed fresh 52-week highs, and this is the kind of tape that quietly builds momentum before people realize the trend has already moved. $TECX led the board +16% on heavy volume, no clean catalyst yet, which honestly makes it more interesting than less. Pure price discovery mode. $MRNA +10% and biotech names like MGTX SLDB VRTX all participating, showing this is not a single-name move, it is rotation into higher beta pockets of the market. When breakouts stack like this across different sectors, it usually signals risk appetite is creeping back in even if headlines are quiet. Question is simple. Are you chasing strength or still waiting for confirmation that already came? To my subscribers and future subscribers: When the next bull run starts, this is the type of portfolio performance we are working to build again. Are you going to miss out again?
0 · Reply
ErnieWorthing84
ErnieWorthing84 Jul. 2 at 10:31 PM
$MGTX lol
0 · Reply
EddieHayes
EddieHayes Jul. 2 at 10:30 PM
$MGTX is a good example of how fast secondary biotech names can move once capital rotates into the right pocket. Clinical-stage gene therapy names like this are still binary in nature, but when sentiment shifts toward risk-on, they can reprice aggressively on limited news flow. The core story here is AAV-based gene therapy for rare diseases, which keeps it in a high-upside but high-uncertainty category. These are not slow compounding names, they’re catalyst-driven and often lag until they don’t. This is also where positioning matters: if it’s not in the primary watchlist during accumulation, you often miss the move or end up chasing after expansion has already happened. Fast movers reward focus, not breadth.
0 · Reply
Mikelonggggggggg
Mikelonggggggggg Jul. 2 at 8:22 PM
0 · Reply
GrizzlyBearTurd
GrizzlyBearTurd Jul. 2 at 8:09 PM
$MGTX after 2.5 years of being bewildered this is quite satisfying.
0 · Reply
jlemx
jlemx Jul. 2 at 3:08 PM
$MGTX Can I hope to see three digits here? Sooner or later.
1 · Reply
slinghook67
slinghook67 Jul. 2 at 12:16 PM
$MGTX The FDA's positive momentum towards GT continues as this is very good news for the sector...
1 · Reply
ErnieWorthing84
ErnieWorthing84 Jul. 1 at 8:12 PM
$MGTX We’ll always have Tuesday. See you next Tuesday?
0 · Reply
slinghook67
slinghook67 Jul. 1 at 12:51 AM
$MGTX The new acting Director of CBER is Karim Mikhail and he's got full oversight of Gene Therapies. This is fantastic for the field as he comes from the industry and he's only been with the FDA since 2025. He was previously at Merck for 22 years in various global leadership roles all with a commercial focus. He was then CEO of Amarin Pharma for 2 years. Compared to Prasad's nightmare tenure, this is a DREAM....
2 · Reply
Latest News on MGTX
MeiraGTx Holdings Transcript: AGM 2026

Jun 11, 2026, 10:00 AM EDT - 23 days ago

MeiraGTx Holdings Transcript: AGM 2026


MeiraGTx Holdings Slides: FY 2026

Jun 4, 2026, 3:10 PM EDT - 4 weeks ago

MeiraGTx Holdings Slides: FY 2026


MeiraGTx Holdings Slides: Corporate presentation

Jun 3, 2026, 7:00 AM EDT - 4 weeks ago

MeiraGTx Holdings Slides: Corporate presentation


MeiraGTx reports Q1 EPS (57c), consensus (45c)

2026-05-14T16:16:51.000Z - 7 weeks ago

MeiraGTx reports Q1 EPS (57c), consensus (45c)


MeiraGTx Holdings Earnings release: Q1 2026

May 14, 2026, 8:00 AM EDT - 7 weeks ago

MeiraGTx Holdings Earnings release: Q1 2026


MeiraGTx Holdings Quarterly report: Q1 2026

May 14, 2026, 8:00 AM EDT - 7 weeks ago

MeiraGTx Holdings Quarterly report: Q1 2026


MeiraGTx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

MeiraGTx Holdings Proxy statement: Proxy filing


MeiraGTx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

MeiraGTx Holdings Proxy statement: Proxy filing


MeiraGTx price target raised to $30 from $26 at Piper Sandler

2026-04-22T11:34:08.000Z - 2 months ago

MeiraGTx price target raised to $30 from $26 at Piper Sandler

JNJ


MeiraGTx price target raised to $24 from $16 at RBC Capital

2026-04-17T13:19:37.000Z - 2 months ago

MeiraGTx price target raised to $24 from $16 at RBC Capital


MeiraGTx announces three-year data from Phase 1 AQUAx study

2026-04-16T12:00:53.000Z - 2 months ago

MeiraGTx announces three-year data from Phase 1 AQUAx study


MeiraGTx Holdings Transcript: KOL event

Apr 16, 2026, 8:00 AM EDT - 2 months ago

MeiraGTx Holdings Transcript: KOL event


MeiraGTx Holdings Press release: KOL event

Apr 16, 2026, 8:00 AM EDT - 2 months ago

MeiraGTx Holdings Press release: KOL event


MeiraGTx Holdings Slides: KOL event

Apr 16, 2026, 8:00 AM EDT - 2 months ago

MeiraGTx Holdings Slides: KOL event


MeiraGTx Holdings Slides: Corporate presentation

Apr 16, 2026, 6:00 AM EDT - 2 months ago

MeiraGTx Holdings Slides: Corporate presentation


MeiraGTx price target lowered to $18 from $20 at Evercore ISI

2026-04-01T11:59:11.000Z - 3 months ago

MeiraGTx price target lowered to $18 from $20 at Evercore ISI


MeiraGTx price target lowered to $26 from $30 at Piper Sandler

2026-03-27T11:01:18.000Z - 3 months ago

MeiraGTx price target lowered to $26 from $30 at Piper Sandler


MeiraGTx price target raised to $16 from $14 at BofA

2026-03-27T10:26:11.000Z - 3 months ago

MeiraGTx price target raised to $16 from $14 at BofA


MeiraGTx Holdings Annual report: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 3 months ago

MeiraGTx Holdings Annual report: Q4 2025


MeiraGTx Holdings Earnings release: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 3 months ago

MeiraGTx Holdings Earnings release: Q4 2025


MeiraGTx price target lowered to $14 from $15 at BofA

2026-01-06T15:25:58.000Z - 6 months ago

MeiraGTx price target lowered to $14 from $15 at BofA


MeiraGTx initiated with a Buy at H.C. Wainwright

2025-11-24T11:15:40.000Z - 7 months ago

MeiraGTx initiated with a Buy at H.C. Wainwright


MeiraGTx Holdings Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 8 months ago

MeiraGTx Holdings Quarterly report: Q3 2025


MeiraGTx Holdings Earnings release: Q3 2025

Nov 13, 2025, 8:00 AM EST - 8 months ago

MeiraGTx Holdings Earnings release: Q3 2025


MeiraGTx Holdings Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

MeiraGTx Holdings Quarterly report: Q2 2025


MeiraGTx Holdings Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

MeiraGTx Holdings Earnings release: Q2 2025


MeiraGTx Holdings Slides: Corporate Presentation

Jul 1, 2025, 7:00 AM EDT - 1 year ago

MeiraGTx Holdings Slides: Corporate Presentation


MeiraGTx Holdings Quarterly report: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

MeiraGTx Holdings Quarterly report: Q1 2025


MeiraGTx Holdings Earnings release: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

MeiraGTx Holdings Earnings release: Q1 2025


MeiraGTx Holdings Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Earnings release: Q4 2024

Mar 12, 2025, 7:00 PM EDT - 1 year ago

MeiraGTx Holdings Earnings release: Q4 2024


MeiraGTx Holdings Annual report: Q4 2024

Mar 12, 2025, 7:00 PM EDT - 1 year ago

MeiraGTx Holdings Annual report: Q4 2024


MeiraGTx Holdings Transcript: Study Update

Feb 21, 2025, 8:00 AM EST - 1 year ago

MeiraGTx Holdings Transcript: Study Update


MeiraGTx Holdings Press release: Study Update

Feb 21, 2025, 8:00 AM EST - 1 year ago

MeiraGTx Holdings Press release: Study Update


MeiraGTx Holdings Slides: Study Update

Feb 21, 2025, 8:00 AM EST - 1 year ago

MeiraGTx Holdings Slides: Study Update


MeiraGTx Holdings Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

MeiraGTx Holdings Quarterly report: Q3 2024


MeiraGTx Holdings Quarterly report: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 2 years ago

MeiraGTx Holdings Quarterly report: Q2 2024


MeiraGTx Holdings Earnings release: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 2 years ago

MeiraGTx Holdings Earnings release: Q2 2024


MeiraGTx Holdings Quarterly report: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

MeiraGTx Holdings Quarterly report: Q1 2024


MeiraGTx Holdings Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

MeiraGTx Holdings Earnings release: Q1 2024


MeiraGTx Holdings Proxy statement: Proxy Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Proxy statement: Proxy Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx to Participate in Upcoming Investor Conferences

Apr 24, 2024, 4:30 PM EDT - 2 years ago

MeiraGTx to Participate in Upcoming Investor Conferences


MeiraGTx Holdings Annual report: Q4 2023

Mar 14, 2024, 7:00 AM EDT - 2 years ago

MeiraGTx Holdings Annual report: Q4 2023


MeiraGTx Holdings Earnings release: Q4 2023

Mar 14, 2024, 7:00 AM EDT - 2 years ago

MeiraGTx Holdings Earnings release: Q4 2023


MeiraGTx Holdings Slides: Corporate Presentation

Dec 21, 2023, 7:30 AM EST - 2 years ago

MeiraGTx Holdings Slides: Corporate Presentation


MeiraGTx Holdings Registration statement: Registration Filing

Dec 21, 2023, 7:00 AM EST - 2 years ago

MeiraGTx Holdings Registration statement: Registration Filing


MeiraGTx Holdings Quarterly report: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

MeiraGTx Holdings Quarterly report: Q3 2023


MeiraGTx Holdings Earnings release: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

MeiraGTx Holdings Earnings release: Q3 2023


MeiraGTx shares jump as Sanofi invests in gene therapy

Oct 30, 2023, 8:28 AM EDT - 2 years ago

MeiraGTx shares jump as Sanofi invests in gene therapy

SNY


MeiraGTx Holdings Quarterly report: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

MeiraGTx Holdings Quarterly report: Q2 2023


MeiraGTx Holdings Earnings release: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

MeiraGTx Holdings Earnings release: Q2 2023


MeiraGTx Holdings Registration statement: Registration Filing

Aug 3, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Registration statement: Registration Filing


MeiraGTx Holdings Registration statement: Registration Filing

Aug 3, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Registration statement: Registration Filing


MeiraGTx Holdings Transcript: Study Update

Jun 27, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Transcript: Study Update


MeiraGTx Holdings Press release: Study Update

Jun 27, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Press release: Study Update


MeiraGTx Holdings Slides: Study Update

Jun 27, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Slides: Study Update


MeiraGTx Holdings Quarterly report: Q1 2023

May 11, 2023, 7:00 AM EDT - 3 years ago

MeiraGTx Holdings Quarterly report: Q1 2023


MeiraGTx Holdings Earnings release: Q1 2023

May 11, 2023, 7:00 AM EDT - 3 years ago

MeiraGTx Holdings Earnings release: Q1 2023


MeiraGTx Holdings Proxy statement: Proxy Filing

Apr 27, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Proxy statement: Proxy Filing

Apr 27, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Annual report: Q4 2022

Mar 14, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Annual report: Q4 2022


MeiraGTx Holdings Earnings release: Q4 2022

Mar 14, 2023, 8:00 AM EDT - 3 years ago

MeiraGTx Holdings Earnings release: Q4 2022


MeiraGTx Holdings Proxy statement: Proxy Filing

Jan 20, 2023, 7:00 AM EST - 3 years ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Proxy statement: Proxy Filing

Dec 23, 2022, 7:00 AM EST - 3 years ago

MeiraGTx Holdings Proxy statement: Proxy Filing


MeiraGTx Holdings Transcript: Study Update

Dec 13, 2022, 8:00 AM EST - 3 years ago

MeiraGTx Holdings Transcript: Study Update


MeiraGTx Holdings Press release: Study Update

Dec 13, 2022, 8:00 AM EST - 3 years ago

MeiraGTx Holdings Press release: Study Update


MeiraGTx Holdings Slides: Study Update

Dec 13, 2022, 8:00 AM EST - 3 years ago

MeiraGTx Holdings Slides: Study Update


MeiraGTx Holdings Quarterly report: Q3 2022

Nov 10, 2022, 7:00 AM EST - 3 years ago

MeiraGTx Holdings Quarterly report: Q3 2022


MeiraGTx Holdings Earnings release: Q3 2022

Nov 10, 2022, 7:00 AM EST - 3 years ago

MeiraGTx Holdings Earnings release: Q3 2022


MeiraGTx Holdings Quarterly report: Q2 2022

Aug 11, 2022, 7:00 AM EDT - 4 years ago

MeiraGTx Holdings Quarterly report: Q2 2022


MeiraGTx Holdings Earnings release: Q2 2022

Aug 11, 2022, 7:00 AM EDT - 4 years ago

MeiraGTx Holdings Earnings release: Q2 2022


MeiraGTx Holdings Transcript: Study Result

Jun 28, 2022, 8:00 AM EDT - 4 years ago

MeiraGTx Holdings Transcript: Study Result


MeiraGTx Holdings Press release: Study Result

Jun 28, 2022, 8:00 AM EDT - 4 years ago

MeiraGTx Holdings Press release: Study Result


MeiraGTx Holdings Slides: Study Result

Jun 28, 2022, 8:00 AM EDT - 4 years ago

MeiraGTx Holdings Slides: Study Result


topstockalerts
topstockalerts Jul. 3 at 10:41 PM
$MGTX not chasing but definitely watching this closely
0 · Reply
EddieHayes
EddieHayes Jul. 2 at 10:35 PM
$TECX $MRNA $MGTX and a cluster of names just printed fresh 52-week highs, and this is the kind of tape that quietly builds momentum before people realize the trend has already moved. $TECX led the board +16% on heavy volume, no clean catalyst yet, which honestly makes it more interesting than less. Pure price discovery mode. $MRNA +10% and biotech names like MGTX SLDB VRTX all participating, showing this is not a single-name move, it is rotation into higher beta pockets of the market. When breakouts stack like this across different sectors, it usually signals risk appetite is creeping back in even if headlines are quiet. Question is simple. Are you chasing strength or still waiting for confirmation that already came? To my subscribers and future subscribers: When the next bull run starts, this is the type of portfolio performance we are working to build again. Are you going to miss out again?
0 · Reply
ErnieWorthing84
ErnieWorthing84 Jul. 2 at 10:31 PM
$MGTX lol
0 · Reply
EddieHayes
EddieHayes Jul. 2 at 10:30 PM
$MGTX is a good example of how fast secondary biotech names can move once capital rotates into the right pocket. Clinical-stage gene therapy names like this are still binary in nature, but when sentiment shifts toward risk-on, they can reprice aggressively on limited news flow. The core story here is AAV-based gene therapy for rare diseases, which keeps it in a high-upside but high-uncertainty category. These are not slow compounding names, they’re catalyst-driven and often lag until they don’t. This is also where positioning matters: if it’s not in the primary watchlist during accumulation, you often miss the move or end up chasing after expansion has already happened. Fast movers reward focus, not breadth.
0 · Reply
Mikelonggggggggg
Mikelonggggggggg Jul. 2 at 8:22 PM
0 · Reply
GrizzlyBearTurd
GrizzlyBearTurd Jul. 2 at 8:09 PM
$MGTX after 2.5 years of being bewildered this is quite satisfying.
0 · Reply
jlemx
jlemx Jul. 2 at 3:08 PM
$MGTX Can I hope to see three digits here? Sooner or later.
1 · Reply
slinghook67
slinghook67 Jul. 2 at 12:16 PM
$MGTX The FDA's positive momentum towards GT continues as this is very good news for the sector...
1 · Reply
ErnieWorthing84
ErnieWorthing84 Jul. 1 at 8:12 PM
$MGTX We’ll always have Tuesday. See you next Tuesday?
0 · Reply
slinghook67
slinghook67 Jul. 1 at 12:51 AM
$MGTX The new acting Director of CBER is Karim Mikhail and he's got full oversight of Gene Therapies. This is fantastic for the field as he comes from the industry and he's only been with the FDA since 2025. He was previously at Merck for 22 years in various global leadership roles all with a commercial focus. He was then CEO of Amarin Pharma for 2 years. Compared to Prasad's nightmare tenure, this is a DREAM....
2 · Reply
jlemx
jlemx Jun. 30 at 7:24 PM
$MGTX I got in here at $4.22 and I'm holding tight; I'm hoping for some 10x gains and to make up for my losses on $SGMO. That was another gene therapy biotech with similar potential, but with the exact opposite kind of management which is what sank it. It's the complete opposite situation.
3 · Reply
ErnieWorthing84
ErnieWorthing84 Jun. 30 at 5:40 PM
$MGTX Guys
0 · Reply
waterlock
waterlock Jun. 30 at 2:54 PM
$MGTX Nice action
0 · Reply
NyseDayTrader
NyseDayTrader Jun. 30 at 2:23 PM
$MGTX i stopped following this one for some time. Got away after years of waiting
0 · Reply
Bogy99
Bogy99 Jun. 30 at 12:50 PM
$MGTX re-ratings are painful for those on the sidelines and of course shorts. I begged those shorts to cover below $10. Was a gift I said. They didn’t listen. 5.5mm shares short. What to expect ? Thanks to new FDA and our friends at $QURE , the new baseline valuation is 1x sales. For Meira that is $5B or ~ $50 per share. Because the shorts are dumb and don’t listen , they will likely drive us to that $50 number sooner rather than later. If you’re on the sidelines watching. Don’t wait, act now. You have a 4-5 bagger (12 months max) just waiting for you. As always, I do wish you well. (Unless you’re short). You guys are screwed!
1 · Reply
slinghook67
slinghook67 Jun. 30 at 4:43 AM
$MGTX Meira just announced a pretty massive RSU grant for Richard Giroux, a whopping 980k shares. While they naturally haven't vested yet, that's a cool $12M in current value. He's been side by side with Zandy for years, but I find it interesting that his public profile is seemingly non-existent. That's not necessarily a bad thing of course, it's just a bit unusual given his long tenure and current titles of CFO / COO. If I am not mistaken he's co-presented at a couple investor conferences, but it's always Zandy that's front and center.
2 · Reply
slinghook67
slinghook67 Jun. 30 at 12:51 AM
$MGTX Not sure if this is a positive or negative for the GT field..... If anyone has any perspective please share.
1 · Reply
ErnieWorthing84
ErnieWorthing84 Jun. 29 at 8:30 PM
$MGTX https://seekingalpha.com/article/4918470-meiragtx-the-market-is-missing-the-manufacturing-pivot
0 · Reply
jlemx
jlemx Jun. 29 at 1:14 PM
$MGTX Isn't it time for MGTX to start soaring?
0 · Reply
Helpmrwizard
Helpmrwizard Jun. 26 at 8:00 PM
$MGTX dang!
1 · Reply
ErnieWorthing84
ErnieWorthing84 Jun. 26 at 2:27 PM
$MGTX Anyone got access to RJ? https://x.com/RJResearch/status/2069800133827399688
0 · Reply
ErnieWorthing84
ErnieWorthing84 Jun. 25 at 8:03 PM
$MGTX Sorry
2 · Reply